Alan Lewis: Embryonic Stem Cell Therapies for diabetes

Posted: Published on September 24th, 2011

This post was added by Dr. Richardson



Embryonic stem cells have the potential to help treat 70 or more diseases, but developing those new therapies will take time. Alan Lewis is president and CEO of Novocell, a La Jolla-based company that has been developing a potential therapy for diabetes. Novocell has a CIRM grant to assemble a team of researchers who will accelerate the time it takes to get that potential therapy to the FDA for clinical trials.

Excerpt from:
Alan Lewis: Embryonic Stem Cell Therapies for diabetes

Related Posts
This entry was posted in FDA Stem Cell Trials. Bookmark the permalink.

Comments are closed.